I need help for a sistematic review writing for the ESMO Targeted Anticancer Therapies Congress 2025. 

Abstract submission categories

• Antibody-based therapies
• Cellular and gene therapies
• DNA damage repair and epigenetics
• Immunotherapy
• Kinase-targeting agents and cell signalling modulators
• Molecular profiling applications
• Artificial intelligence (AI) and digital therapeutics
• Methodological, financial and regulatory aspects
• Miscellaneous

Presentation of accepted abstracts

The ESMO TAT 2025 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:

• Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
• Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
• Poster – Display session for review, discussion and questions. The presenting authors must be available for Q&A to represent their work.

First and presenting authors must register for the Congress and present onsite.

Detailed instructions for the preparation of slide presentations and posters will be made available on the ESMO website by end-December 2024 (in the “Information for Presenters” section) along with scheduling notices.

Accepted abstracts will be published online only in the ESMO TAT 2025 Abstract Book, a supplement to the official ESMO journal, ESMO Open.

ESMO Merit Travel Grants

A limited number of ESMO Merit Travel Grants to ESMO TAT 2025 are available, upon application, to first authors (= presenters) who submit abstracts considered to be deserving of recognition. Candidates must be ESMO Members under the age of 40. Selection will be made by the ESMO TAT 2025 Scientific Committee on a competitive basis from among the accepted abstracts.